132 related articles for article (PubMed ID: 1707023)
1. Utility of anti-carcinoembryonic antigen monoclonal antibodies for differentiating ovarian adenocarcinomas from gastrointestinal metastasis to the ovary.
Pavelic ZP; Pavelic L; Pavelic K; Peacock JS
Gynecol Oncol; 1991 Feb; 40(2):112-7. PubMed ID: 1707023
[TBL] [Abstract][Full Text] [Related]
2. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
3. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
Chou YY; Jeng YM; Kao HL; Chen T; Mao TL; Lin MC
Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
[TBL] [Abstract][Full Text] [Related]
5. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies.
Sheahan K; O'Brien MJ; Burke B; Dervan PA; O'Keane JC; Gottlieb LS; Zamcheck N
Am J Clin Pathol; 1990 Aug; 94(2):157-64. PubMed ID: 1695478
[TBL] [Abstract][Full Text] [Related]
6. D-14 monoclonal antibody to carcinoembryonic antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human colorectal carcinoma, tumors of non-colorectal origin and normal tissues.
Pavelic ZP; Petrelli NJ; Herrera L; Vaughan MM; Paecock JS; Pavelic L
J Cancer Res Clin Oncol; 1990; 116(1):51-6. PubMed ID: 2312605
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of carcinoembryonic antigen in early gastric adenocarcinomas versus benign gastric lesions defined by monoclonal antibodies reactive with restricted antigen epitopes.
Ohuchi N; Wunderlich D; Fujita J; Colcher D; Muraro R; Nose M; Schlom J
Cancer Res; 1987 Jul; 47(13):3565-71. PubMed ID: 3555774
[TBL] [Abstract][Full Text] [Related]
8. Human alveolar macrophage-56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas.
Fowler LJ; Maygarden SJ; Novotny DB
Hum Pathol; 1994 Jul; 25(7):666-70. PubMed ID: 8026826
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
Brown RW; Campagna LB; Dunn JK; Cagle PT
Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
Meenakshi A; Kumar NS; Vijayshanker SG
Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen in primary and metastatic ovarian tumors.
Fleuren GJ; Nap M
Gynecol Oncol; 1988 Jul; 30(3):407-15. PubMed ID: 2839395
[TBL] [Abstract][Full Text] [Related]
12. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
[TBL] [Abstract][Full Text] [Related]
13. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.
Delahaye M; Hoogsteden HC; Van der Kwast TH
J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
16. Comparison of glycoprotein expression between ovarian and colon adenocarcinomas.
Multhaupt HA; Arenas-Elliott CP; Warhol MJ
Arch Pathol Lab Med; 1999 Oct; 123(10):909-16. PubMed ID: 10506443
[TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical discrimination of endometrioid adenocarcinomas.
Dabbs DJ; Sturtz K; Zaino RJ
Hum Pathol; 1996 Feb; 27(2):172-7. PubMed ID: 8617459
[TBL] [Abstract][Full Text] [Related]
18. Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.
Ohuchi N; Simpson JF; Colcher D; Schlom J
Int J Cancer; 1987 Dec; 40(6):726-33. PubMed ID: 2447021
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
Berezowski K; Stastny JF; Kornstein MJ
Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
[TBL] [Abstract][Full Text] [Related]
20. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
Dai L; Song Q; Li L; Zhong D; Hui Y
Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
